Stay updated on Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The new screenshot shows only cosmetic/layout updates to the page header and navigation, and core study details appear unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:34:20.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Adds a government-funding notice with operating-status guidance and announces a software version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    11%
    Check dated 2025-10-05T10:30:29.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0: version metadata updated; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:24:19.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.7%
    Check dated 2025-09-13T17:35:40.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.7%
    Check dated 2025-09-06T14:56:18.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information.
    Difference
    21%
    Check dated 2025-08-30T11:46:23.000Z thumbnail image

Stay in the know with updates to Naptumomab + Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Naptumomab + Durvalumab in Solid Tumors Clinical Trial page.